INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal resource in the fields of pediatric otorhinolaryngology, pediatrics, and related medical disciplines. With a historical publication record spanning from 1979 to 2024, this journal is dedicated to advancing research and clinical practice in the diagnosis and treatment of ear, nose, and throat disorders in children. As evidenced by its 2023 rankings, the journal maintains a commendable position within the Q2 category of its field, reflecting its impact and the quality of research it disseminates, ranking #43 out of 123 in Otorhinolaryngology and #131 out of 330 in Pediatrics. Researchers, clinicians, and students alike can benefit from a wealth of studies and reviews designed to inform and enhance pediatric care. Although the journal does not currently offer open access, it remains an indispensable tool for those seeking to stay at the forefront of pediatric health and otolaryngological innovations.

LARYNGOSCOPE, published by Wiley, is a premier journal in the field of Otorhinolaryngology, boasting an impressive impact factor and ranked #8 out of 123 in its category, placing it in the 93rd percentile among its peers. Since its inception in 1896, the journal has served as a vital platform for disseminating high-quality research, innovative clinical practices, and advancements in the study of ear, nose, and throat diseases. The journal is committed to providing comprehensive coverage of original research, case studies, and reviews that shape the future of Otorhinolaryngology. With a notable Q1 category ranking in 2023, it remains at the forefront of medical publications, making it an essential resource for researchers, health professionals, and students who seek to stay abreast of the latest developments in the field. Although not an Open Access journal, it provides valuable insights that contribute to the understanding and treatment of complex disorders within otolaryngology. The journal’s dedication to excellence ensures its readers receive cutting-edge information that is critical for advancing their work and enhancing patient care.

Acta Otorhinolaryngologica Italica is a prestigious peer-reviewed journal published by PACINI EDITORE, dedicated to advancing the field of otorhinolaryngology. Since its inception in 1981, the journal has established itself as an essential resource for researchers, clinicians, and students interested in the latest developments in ear, nose, and throat medicine. With an impressive Q2 category ranking in the field of Otorhinolaryngology as per Scopus rankings, the journal maintains a significant presence internationally, ranked #39 out of 123 in its category and placing it in the 68th percentile. Acta Otorhinolaryngologica Italica transitioned to an Open Access model in 2018, ensuring that groundbreaking research is accessible to a broader audience, thus fostering collaboration and innovation across the global medical community. With an ongoing commitment to quality and rigor, this journal serves as a valuable platform for disseminating critical findings, case studies, and reviews that contribute to the enhancement of healthcare practices and patient outcomes in otorhinolaryngology.

Bangladesh Journal of Otorhinolaryngology is a prominent peer-reviewed journal dedicated to the field of otorhinolaryngology, providing a platform for the dissemination of innovative research and clinical findings related to ear, nose, and throat (ENT) disorders. Published by the SOC OTORHINOLARYNGOLOGISTS & HEAD NECK SURGEONS BANGLADESH, the journal aims to enhance medical knowledge, improve clinical practices, and promote evidence-based treatments among healthcare professionals. As an academic resource, it serves not only local but also international audiences, facilitating a deeper understanding of the challenges and advancements in ENT healthcare. Although published in Bangladesh, the journal's rigorous peer-review process and commitment to high academic standards position it as a significant contributor to global ENT research discourse. While currently not an open-access journal, it encourages subscription and institutional access, helping researchers and practitioners stay abreast of cutting-edge developments in the field.

Acta Phlebologica, published by EDIZIONI MINERVA MEDICA, is a pivotal journal dedicated to the field of cardiovascular medicine, specifically focusing on the complexities of venous diseases and phlebology. With an ISSN of 1593-232X and an E-ISSN of 1827-1766, this journal serves as a platform for researchers, clinicians, and students to disseminate their findings and insights relevant to venous health. While it currently holds a Q4 status in the Cardiology and Cardiovascular Medicine category, its emphasis on critical aspects of clinical practice and research aims to improve understanding and management of venous disorders. The journal, which has been in circulation since 2013, operates on a subscription basis, ensuring access to high-quality, peer-reviewed content. As the readership grows, Acta Phlebologica aspires to enrich knowledge within the cardiovascular community, fostering advancements in patient care and innovative research.

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.

The International Forum of Allergy & Rhinology, published by Wiley, is a leading journal dedicated to advancing the field of allergy, rhinology, and related health issues. With an ISSN of 2042-6976 and an E-ISSN of 2042-6984, this esteemed journal showcases high-quality research and innovative findings by publishing original articles, reviews, and clinical case studies. As of 2023, it holds impressive rankings within the Scopus metrics, placing it in the top 2% for Medicine in Otorhinolaryngology and in the top 16% for Immunology and Allergy, highlighting its influence and credibility in these specialized fields. Operating without an open access model, the journal aims to offer comprehensive insights into the diagnosis and treatment of allergic conditions and their impact on rhinology, fostering a deeper understanding among researchers and practitioners. Located in Hoboken, NJ, the journal has been at the forefront of scientific exploration since its inception in 2011, continuing to play a pivotal role in informing the academic community and influencing clinical practice up to 2024 and beyond.

ACTA OTO-LARYNGOLOGICA is a prestigious academic journal focusing on the field of otorhinolaryngology, published by Taylor & Francis Ltd in the United Kingdom. With an ISSN of 0001-6489 and E-ISSN 1651-2251, this journal has been a cornerstone in the dissemination of research in otolaryngology since its inception in 1918. It maintains a solid impact factor in the scholarly community, categorized in 2023 as Q3 in Medicine (miscellaneous) and Q2 specifically in Otorhinolaryngology, indicating its significance and quality of published work. Researchers and practitioners benefit from comprehensive articles that offer insights and advancements in clinical practices, surgical techniques, and emerging trends in the field. Though it follows a subscription model, ACTA OTO-LARYNGOLOGICA strives to remain accessible for professionals seeking the latest research findings that can enhance patient care and clinical decision-making. By fostering a platform for quality scholarship, the journal plays an essential role in advancing the science and practice of otorhinolaryngology, making it invaluable for researchers, medical professionals, and students alike.

Gastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.

Egyptian Journal of Otolaryngology (EJOT) is a premier open access journal dedicated to advancing the field of otorhinolaryngology. Published by Springer, the journal has been an essential resource for researchers and practitioners since its transition to open access in 2012. With an ISSN of 1012-5574 and E-ISSN 2090-8539, EJOT aims to facilitate the dissemination of high-quality research, covering a broad spectrum of topics within otolaryngology. The journal's significance is underscored by its current ranking in the Q3 category of the Scopus Otorhinolaryngology category, and it is positioned in the 23rd percentile of its field, reflecting its commitment to scholarly excellence. Researchers, professionals, and students alike will find valuable insights and innovative studies in the journal's articles, contributing to ongoing education and the advancement of best practices in ear, nose, and throat medicine. The journal is based in Germany with its operations centered at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, UNITED STATES, ensuring a global reach in the academic community.